Quanterix Corporation Operating Lease Liability
Quanterix Corporation (QTRX) had Operating Lease Liability of $33.39 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability $33.39M.
- 2026-03-31: Operating Lease, Liability $35.34M.
- 2025-12-31: Operating Lease, Liability $37.24M.
- 2025-09-30: Operating Lease, Liability $39.20M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $33.39M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $35.34M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $37.24M 10-K · filed 2026-03-02 |
| 2025-09-30 | $39.20M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $35.53M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $36.41M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $37.37M 10-K · filed 2025-03-17 |
| 2024-09-30 | $38.49M 10-Q · filed 2024-12-26 |
| 2024-06-30 | $39.58M 10-Q/A · filed 2024-12-26 |
| 2024-03-31 | $40.45M 10-Q/A · filed 2024-12-26 |
| 2023-12-31 | $41.46M 10-K/A · filed 2024-12-26 |
| 2023-09-30 | $42.40M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $43.36M 10-Q · filed 2023-08-08 |
| 2022-12-31 | $44.10M 10-K · filed 2023-03-06 |
| 2022-09-30 | $42.96M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $45.83M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $45.45M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $21.89M 10-K · filed 2022-03-01 |
| 2020-12-31 | $23.13M 10-K · filed 2021-03-05 |
| 2020-09-30 | $23.32M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $23.19M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $23.05M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |